Plunkett Research Online: bluebird bio Inc

BLUEBIRD BIO INC (BLUE:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Bluebird Bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company’s gene therapy procedures aim to genetically modify a patient’s cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird’s revenue i.....



bluebird bio Inc
Ticker: BLUE
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 339 499-9300
Fax:
Address: 150 Second Street
Cambridge, MA 02141 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Jeffrey WalshCFO
Daniel LynchChairman of the Board/Director
See More
Bluebird Bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company’s gene therapy procedures aim to genetically modify a patient’s cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird’s revenue i.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: